Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroendocrine Tumors 21Meningioma 6Gastro-enteropancreatic neuroendocrine tumor 6Pheochromocytoma 3Paraganglioma 3Prostatic Neoplasms 2Neuroblastoma 2Medulloblastoma 2Glioma 2Glioblastoma 2Ependymoma 2Carcinoma, Merkel Cell 2Adenoma, Islet Cell 2Somatostatin Receptor-positive Neuroendocrine Tumor 1Sarcoma, Synovial 1Recurrence 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Metastatic Digestive System Neuroendocrine Tumor G1 1Hypertension 1Extensive Stage Small Cell Lung Cancer 1Esthesioneuroblastoma, Olfactory 1Disease Progression 1Digestive System Neuroendocrine Tumor G1 1Diffuse Intrinsic Pontine Glioma 1Central Nervous System Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma 1

Interventions

Etoposide 7Cisplatin 7fludarabine 4Cyclophosphamide 4fludarabine phosphate 3Paclitaxel 3Carboplatin 3Bleomycin 3Automobiles 3pembrolizumab 2etoposide phosphate 2Vorinostat 2Sirolimus 2Mesna 2Ifosfamide 2Drug Therapy 2130-nm albumin-bound paclitaxel 2tremelimumab 1tozuleristide 1sodium thiosulfate 1repotrectinib 1pralsetinib 1pegfilgrastim 1lutetium Lu 177 dotatate 1durvalumab 1cabozantinib 1Watchful Waiting 1Teniposide 1Surveys and Questionnaires 1Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × lutetium Lu 177 dotatate × 1 year × Clear all
NCT05278208 2026-04-13

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Nationwide Children's Hospital

Phase 1/2 Recruiting
65 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡